Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Oxygen on Ischemia-Reperfusion Injury Mechanisms in Healthy Volunteers
NCT02286544Phase 1Completed
- Sponsor
- Karolinska Institutet
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oxygen in myocardial infarction (MI) and reperfusion injury (IRI) (3 arms), sponsored by Karolinska Institutet. Primary endpoints: Plasma concentration levels of biomarkers of oxidative stress at 8 hours, Plasma concentration levels of biomarkers of apoptosis at 8 hours and 2 more. Started Oct 2014; status: completed.
02
Drugs
oxygen
03
Conditions
myocardial infarction (MI)reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02286544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286544.